ConductScience.org, home

Paper25567367

Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers.

An G and 5 others. AAPS J, 2015. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers. Papers, record 25567367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25567367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers.
PubMed
Journal
AAPS J
PubMed
Year
2015
PubMed
Publication types
Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.47
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1An GGuohua
2Liu WWei
3Duan WRW Rachel
4Nothaft WWolfram
5Awni WWalid
6Dutta SSandeep

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcium Channel BlockersMajor topic
Heterocyclic Compounds, 2-RingMajor topic
Models, BiologicalMajor topic
SulfonamidesMajor topic
Uric AcidMajor topic
Adolescent
Adult
Aged
Computer Simulation
Dose-Response Relationship, Drug
Double-Blind Method
Female
Gout
Humans
Male
Middle Aged
Sex Factors
Young Adult
Benzenesulfonamides

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in25676842Erratum to: population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers.https://conductscience.org/library/papers/25676842

Source PubMed

Download CSV of comments and corrections

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124726441A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.Biochem Pharmacol2014https://conductscience.org/library/papers/24726441PubMed
211177768Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.Curr Rheumatol Rep2001https://conductscience.org/library/papers/11177768PubMed
312024214Molecular identification of a renal urate anion exchanger that regulates blood urate levels.Nature2002https://conductscience.org/library/papers/12024214PubMed
41027698Current therapy of gout and hyperuricemia.Hosp Pract1976https://conductscience.org/library/papers/1027698PubMed
56691361Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.Am J Med1984https://conductscience.org/library/papers/6691361PubMed
68552148The management of gout.N Engl J Med1996https://conductscience.org/library/papers/8552148PubMed
99849314Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.Ann Rheum Dis1998https://conductscience.org/library/papers/9849314PubMed
1015919000Renal urate handling: clinical relevance of recent advances.Curr Rheumatol Rep2005https://conductscience.org/library/papers/15919000PubMed
1121800283Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.Arthritis Rheum2011https://conductscience.org/library/papers/21800283PubMed
1219692116Gout.Lancet2010https://conductscience.org/library/papers/19692116PubMed
1318729537Febuxostat.Drugs2008https://conductscience.org/library/papers/18729537PubMed
1417278930New insights into renal transport of urate.Curr Opin Rheumatol2007https://conductscience.org/library/papers/17278930PubMed
1516707532EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).Ann Rheum Dis2006https://conductscience.org/library/papers/16707532PubMed
1616820043Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.Arthritis Res Ther2006https://conductscience.org/library/papers/16820043PubMed
1716339094Febuxostat compared with allopurinol in patients with hyperuricemia and gout.N Engl J Med2005https://conductscience.org/library/papers/16339094PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42515693Population Pharmacokinetic Analysis and Modelling of Serum Uric Acid Dynamics in Patients Treated with Favipiravir.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515693PubMed
41340907Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects.Drug Des Devel Ther2025https://conductscience.org/library/papers/41340907PubMed
33110473Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity.Oxid Med Cell Longev2020https://conductscience.org/library/papers/33110473PubMed
31977576The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.J Hypertens2020https://conductscience.org/library/papers/31977576PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SLC22A12116085PubTator's text mininghttps://conductscience.org/library/genes/116085

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25567367

GET https://conductscience.org/api/papers/v1/25567367/authors